CRBU reports updated phase-1 data for allogeneic CAR-T for NHL—seeks to raise $115M* cash in public offering: https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://finance.yahoo.com/news/caribou-biosciences-announces-proposed-public-200300180.html *Assuming exercise of underwriter’s option.